You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Merck
Colorcon
McKesson
Dow
Express Scripts

Last Updated: February 24, 2020

DrugPatentWatch Database Preview

EVICEL FIBRIN SEALANT (HUMAN) Drug Profile


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Summary for Tradename: EVICEL FIBRIN SEALANT (HUMAN)
Recent Clinical Trials for EVICEL FIBRIN SEALANT (HUMAN)

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Montefiore Medical CenterPhase 3
University of MilanN/A
Ethicon, Inc.Phase 4

See all EVICEL FIBRIN SEALANT (HUMAN) clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Boehringer Ingelheim
Johnson and Johnson
McKesson
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.